Heparin Gilvasan

Heparin Gilvasan is a prescription‑only product that contains the active ingredient heparin sodium for intravenous administration. Marketed in the European Union, it is formulated as an injectable anticoagulant used under medical supervision. The medication belongs to the antithrombotic class and works by enhancing antithrombin III activity to reduce clot formation.

Heparin Gilvasan is indicated for several clinical situations where anticoagulation is required.

- Prevention and treatment of deep vein thrombosis (DVT) - Prophylaxis of pulmonary embolism (PE) in at‑risk patients - Anticoagulation during cardiac surgery, including cardiopulmonary bypass - Management of acute coronary syndromes (unstable angina, NSTEMI) - Thromboprophylaxis in major orthopedic procedures such as hip or knee replacement

Side effects of Heparin Gilvasan vary in frequency and severity.

Common: - Minor bleeding or bruising at the injection site - Small drops in platelet count (thrombocytopenia) - Nausea or mild headache - Elevated liver enzymes observed in laboratory tests - Localized pain or irritation

Serious: - Major hemorrhage, including intracranial or gastrointestinal bleeding - Heparin‑induced thrombocytopenia (HIT) with risk of thrombosis - Spinal or epidural hematoma following neuraxial procedures - Severe allergic reaction or anaphylaxis - Adrenal or retroperitoneal hemorrhage

Before initiating Heparin Gilvasan, clinicians should evaluate several safety factors.

- Assess patient’s baseline bleeding risk and recent surgery history - Monitor platelet counts regularly to detect HIT early - Adjust dosing in patients with renal or hepatic impairment - Avoid use in active major bleeding or uncontrolled hypertension - Use with caution during pregnancy (Category B) and lactation - Consider age, body weight, and concomitant antiplatelet therapy when dosing

Heparin Gilvasan may interact with other medications that affect hemostasis or platelet function.

Avoid: - Other systemic anticoagulants (e.g., warfarin, direct oral anticoagulants) - Antiplatelet agents such as aspirin, clopidogrel, or ticagrelor - Thrombolytic drugs (e.g., alteplase, streptokinase) - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that increase bleeding risk

Use with caution: - Certain antibiotics (e.g., ceftriaxone) that can potentiate anticoagulant effect - ACE inhibitors and corticosteroids, which may affect blood pressure and clotting - Herbal supplements like ginkgo biloba, garlic, or ginger that have antiplatelet properties - High‑dose vitamin K preparations, which may interfere with coagulation monitoring